Bioequivalence Study of Fingolimod From Sphingomod 0.5 mg Hard Gelatin Capsules (Hikma Pharma, Egypt) Versus Gilenya 0.5 mg Hard Capsules (Novartis Pharma AG, Basle, Switzerland).
Clinical trial NCT04657744 · COMPLETED
Trial details
- NCT number
- NCT04657744
- Sponsor
- Genuine Research Center, Egypt
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-10
- Primary completion
- 2020-09-28
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.